Carol Gallagher
New Enterprise Associates Partner
location
San Diego, California
investment range
$200k - $40.0m
sweet spot
$10.0m
Carol Gallagher's Past Investments (7)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Pionyr Immunotherapeutics | Series B | $62M (Lead) | Dec 2017 | |
| Metacrine | Series B | $22M (Lead) | Dec 2017 | |
| Good2Go | Seed Round | $7M | Sep 2017 | |
| Good2Go, Inc. | Seed Round | $7M | Sep 2017 | |
| Cleave Biosciences | Series B | $37M (Lead) | Aug 2016 | |
| Millendo Therapeutics | Series B | $62M (Lead) | Jan 2016 | |
| Cleave Biosciences | Series A | $10M | Apr 2013 |
Carol Gallagher's Media
No media found for Carol Gallagher.